SPOTLIGHT: Tough times at Novartis hurt CEO's salary

Novartis had a tough year in 2007: the company managed to report a fourth-quarter profit, but at a level 45 percent less than last year's numbers. And profits aren't the only thing that fell. So did CEO Daniel Vasella's (photo) pay. He took home 17 million Swiss francs--about $15.6 million--which is not chump change, but it's 20 percent less than he made last year. Report

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.